preADMET analysis and clinical aspects of dogs treated with the Organotellurium compound RF07: A possible control for canine visceral leishmaniasis?

Abondanza, 2008, Bcl-2 expression and apoptosis induction in human HL60 leukaemic cells treated with a novel organotellurium(IV) compound RT-04, Food Chem. Toxicol., 46, 2540, 10.1016/j.fct.2008.04.010 Almeida, 2013, Leishmaniasis causes oxidative stress and alteration of oxidative metabolism and viability of neutrophils in dogs, Vet. J., 198, 599, 10.1016/j.tvjl.2013.08.024 Ames, 1972, Carcinogens as frameshift mutagens: metabolites and derivatives of 2-Acetylaminofluorene and other aromatic amine carcinogens, Proc. Natl. Acad. Sci. U. S. A., 69, 3128, 10.1073/pnas.69.11.3128 Amusategui, 2003, Distribution and relationships between clinical and biopathological parameters in canine leishmaniasis, Eur. J. Epidemiol., 18, 147, 10.1023/A:1023090929302 Badaro, 1986, New perspectives on a subclinical form of visceral leishmaniasis, J. Infect. Dis., 154, 1003, 10.1093/infdis/154.6.1003 Berman, 1997, Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years, Clin. Infect. Dis., 24, 684, 10.1093/clind/24.4.684 Bertilsson, 2002, Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs, Br. J. Clin. Pharmacol., 53, 111, 10.1046/j.0306-5251.2001.01548.x Carvalho, 1992, Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi, J. Infect. Dis., 165, 535, 10.1093/infdis/165.3.535 Cunha, 2005, Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B. Bioorg, Med. Chem. Lett., 15, 755, 10.1016/j.bmcl.2004.11.012 Cunha, 2009, Irreversible inhibition of human cathepsins B, L, S and K by hypervalent tellurium compounds, Biol. Chem., 390, 1205, 10.1515/BC.2009.125 da Silva Junior, 2014, Kidney involvement in leishmaniasis--a review, Braz. J. Infect. Dis., 18, 434, 10.1016/j.bjid.2013.11.013 Dai, 2001, Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos, J. Pharmacol. Exp. Ther., 299, 825 Danker, 2014, Early identification of hERG liability in drug discovery programs by automated patch clamp, Front. Pharmacol., 5, 203, 10.3389/fphar.2014.00203 Das, 2016, Epidemiologic correlates of mortality among symptomatic visceral leishmaniasis cases: findings from situation assessment in high endemic foci in India, PLoS Negl. Trop. Dis., 10, 10.1371/journal.pntd.0005150 de Freitas, 2012, Clinical and laboratory alterations in dogs naturally infected by Leishmania chagasi, Rev. Soc. Bras. Med. Trop., 45, 24, 10.1590/S0037-86822012000100006 de Freitas, 2012, Clinical and laboratory alterations in dogs naturally infected by Leishmania chagasi, Rev. da Soc. Bras. Med. Trop. De Rycker, 2018, Challenges and recent progress in drug discovery for tropical diseases, Nature, 559, 498, 10.1038/s41586-018-0327-4 de S. Paladi, 2012, In vitro and in vivo activity of a palladacycle complex on leishmania (Leishmania) amazonensis, PLoS Negl. Trop. Dis., 6 Di, 2009, Drug-like property concepts in pharmaceutical design, Curr. Pharm. Des., 15, 2184, 10.2174/138161209788682479 Duarte, 2016, Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis, Rev. Soc. Bras. Med. Trop., 49, 398, 10.1590/0037-8682-0120-2016 El Chamy Maluf, 2016, Hypervalent organotellurium compounds as inhibitors of P. Falciparum calcium-dependent cysteine proteases, Parasitol. Int., 65, 20, 10.1016/j.parint.2015.09.006 Foti, 2008, CYP2C19 inhibition: the impact of substrate probe selection on in vitro inhibition profiles, Drug Metab. Dispos., 36, 523, 10.1124/dmd.107.019265 Garberg, 1999, Binding of tellurium to hepatocellular selenoproteins during incubation with inorganic tellurite: consequences for the activity of selenium-dependent glutathione peroxidase, Int. J. Biochem. Cell Biol., 31, 291, 10.1016/S1357-2725(98)00113-7 Gontijo, 2004, Leishmaniose visceral no Brasil: quadro atual, desafios e perspectivas, Rev. Bras. Epidemiol., 7, 338, 10.1590/S1415-790X2004000300011 Grimaldi, 2017, Field trial of efficacy of the Leish-tec® vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates, PLoS One, 12, 1, 10.1371/journal.pone.0185438 Halpert, 2014, The effect of the novel tellurium compound AS101 on autoimmune diseases, Autoimmun. Rev., 13, 1230, 10.1016/j.autrev.2014.08.003 Herrera, 2020, An interactive database of Leishmania species distribution in the Americas, Sci. Data, 7, 110, 10.1038/s41597-020-0451-5 Jain, 2015, Vaccines for visceral leishmaniasis: a review, J. Immunol. Methods, 422, 1, 10.1016/j.jim.2015.03.017 Leeson, 2007, The influence of drug-like concepts on decision-making in medicinal chemistry, Nat. Rev. Drug Discov., 10.1038/nrd2445 Lima, 2009, A novel organotellurium compound (RT-01) as a new antileishmanial agent, Korean J. Parasitol., 47, 213, 10.3347/kjp.2009.47.3.213 Lima, 2019, Assessment of histological liver alterations in dogs naturally infected with Leishmania infantum, Parasit. Vectors, 12, 487, 10.1186/s13071-019-3723-1 Lin, 2010, Serum glutamic-oxaloacetic transaminase (GOT) and glutamic-pyruvic transaminase (GPT) levels in children and adolescents with intellectual disabilities, Res. Dev. Disabil., 31, 172, 10.1016/j.ridd.2009.08.005 Lipinski, 2000, Drug-like properties and the causes of poor solubility and poor permeability, J. Pharmacol. Toxicol. Methods, 44, 235, 10.1016/S1056-8719(00)00107-6 Matlashewski, 2001, Leishmania infection and virulence, Med. Microbiol. Immunol., 190, 37, 10.1007/s004300100076 Menon, 2016, Decentralized control of human visceral leishmaniasis in endemic urban areas of Brazil: a literature review, Trop. Med. Health, 44, 9, 10.1186/s41182-016-0011-z Miro, 2009, Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis, Vet. Dermatol., 20, 397, 10.1111/j.1365-3164.2009.00824.x Mitragotri, 2011, Mathematical models of skin permeability: an overview, Int. J. Pharm., 418, 115, 10.1016/j.ijpharm.2011.02.023 Nieto, 2005, Leishmaniosis canina, Terapéutica. Inf. Vet., 6, 34 Nisha, 2016, Docking and ADMET prediction of few GSK-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor, J. Mol. Graph. Model., 65, 100, 10.1016/j.jmgm.2016.03.001 Oliva, 2014, A randomised, double-blind, controlled efficacy trial of the LiESP/QA-21 vaccine in naïve dogs exposed to Two Leishmania infantum transmission seasons, PLoS Negl. Trop. Dis., 8 Oliveira, 2020, Immunity to vector saliva is compromised by short sand fly seasons in endemic regions with temperate climates, Sci. Rep., 10, 7990, 10.1038/s41598-020-64820-9 Oprea, 2000, Property distribution of drug-related chemical databases, J. Comput. Aided Mol. Des., 14, 251, 10.1023/A:1008130001697 Oryan, 2015, Plant-derived compounds in treatment of leishmaniasis, Iran. J. Vet. Res., 16, 1 Oryan, 2016, Worldwide risk factors in leishmaniasis, Asian Pac. J. Trop. Med., 9, 925, 10.1016/j.apjtm.2016.06.021 Padilla, 2009, Use of medaka in toxicity testing, Curr. Protoc. Toxicol., 10.1002/0471140856.tx0110s39 Paltrinieri, 2016, Laboratory tests for diagnosing and monitoring canine leishmaniasis, Vet. Clin. Pathol., 45, 552, 10.1111/vcp.12413 Pereira, 2011, Natural products from Garcinia brasiliensis as Leishmania protease inhibitors, J. Med. Food, 14, 557, 10.1089/jmf.2010.0018 Petitdidier, 2016, Recombinant forms of leishmania amazonensis Excreted/Secreted promastigote surface antigen (PSA) induce protective immune responses in dogs, PLoS Negl. Trop. Dis., 10, 1, 10.1371/journal.pntd.0004614 Pierini, 2019, Neutrophil-to-lymphocyte ratio, nucleated red blood cells and erythrocyte abnormalities in canine systemic inflammatory response syndrome, Res. Vet. Sci., 126, 150, 10.1016/j.rvsc.2019.08.028 Potts, 1992, Predicting skin permeability, Pharm. Res., 9, 663, 10.1023/A:1015810312465 Prival, 1998, Chemicals mutagenic in Salmonella typhimurium strain TA1535 but not in TA100, Mutat. Res., 412, 251, 10.1016/S1383-5718(97)00196-4 Rodrigues, 2015, Natural products: insights into leishmaniasis inflammatory response, Mediators Inflamm., 2015, 10.1155/2015/835910 Salerno Pimentel, 2012, In vitro and in vivo activity of an organic tellurium compound on Leishmania (Leishmania) chagasi, PLoS One, 7 Santin, 2006, Laboratorial accompaniment of kidney funtion of health dogs experimentally treated with therapeutic dosages of amphotericin B, Cienc. Rural, 36, 1816, 10.1590/S0103-84782006000600023 Saurav, 2014, In silico molecular docking, preclinical evaluation of spiroindimicins A-D, lynamicin A and D isolated from deep marine sea derived Streptomyces sp. SCSIO 03032, Interdiscip. Sci., 6, 187, 10.1007/s12539-013-0200-y Scott, 2016, Cutaneous leishmaniasis: immune responses in protection and pathogenesis, Nat. Rev. Immunol., 16, 581, 10.1038/nri.2016.72 Sellon, 1993, Endemic visceral leishmaniasis in a dog from Texas, J. Vet. Intern. Med., 7, 16, 10.1111/j.1939-1676.1993.tb03163.x Singh, 1993, Transdermal drug delivery by passive diffusion and iontophoresis: a review, Med. Res. Rev., 13, 569, 10.1002/med.2610130504 Tariq, 2016, Ethnomedicines and anti-parasitic activities of Pakistani medicinal plants against Plasmodia and Leishmania parasites, Ann. Clin. Microbiol. Antimicrob., 15, 52, 10.1186/s12941-016-0170-0 Torrecilha, 2016, Correlations between peripheral parasite load and common clinical and laboratory alterations in dogs with visceral leishmaniasis, Prev. Vet. Med., 132, 83, 10.1016/j.prevetmed.2016.08.006 Ullah, 2016, Plants as antileishmanial agents: current scenario, Phytother. Res., 30, 1905, 10.1002/ptr.5710 Van Booven, 2010, Cytochrome P450 2C9-CYP2C9, Pharmacogenet. Genomics, 20, 277, 10.1097/FPC.0b013e3283349e84 von Elm, 2007, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, BMJ, 335, 806, 10.1136/bmj.39335.541782.AD Wessler, 2013, The P-glycoprotein transport system and cardiovascular drugs, J. Am. Coll. Cardiol., 61, 2495, 10.1016/j.jacc.2013.02.058 Weyers, 2000, Acute toxicity data: a comprehensive comparison of results of fish, Daphnia,and algae tests with new substances notified in the European Union, Environ. Toxicol. Chem., 19, 1931 Wieslander, 1998, Antioxidative properties of organotellurium compounds in cell systems, Biochem. Pharmacol., 55, 573, 10.1016/S0006-2952(97)00517-0 Zare, 2017, Tracing tellurium and its nanostructures in biology, Biol. Trace Elem. Res., 180, 171, 10.1007/s12011-017-1006-2 Zeni, 1999, Addition reaction of p-Methoxyphenyltellurium trichloride to 3-Hydroxy alkynes, Organometallics, 18, 803, 10.1021/om980738d Zhang, 2020, A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing, Nat. Commun., 11, 3461, 10.1038/s41467-020-17154-z Zhao, 2001, Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors, J. Pharm. Sci., 90, 749, 10.1002/jps.1031